Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2007
05/08/2007US7214367 Orally-administered interferon-tau compositions and methods
05/08/2007US7214266 Methods of crystal optimization
05/08/2007CA2302833C Peptides derived from the attachment (g) protein of respiratory syncytial virus
05/08/2007CA2293612C Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor
05/08/2007CA2273824C Mutants of streptococcal toxin c and methods of use
05/08/2007CA2236968C Accessory functions for use in recombinant aav virion production
05/08/2007CA2185489C Cyclic adhesion inhibitors
05/08/2007CA2137912C Combinatorial polypeptide antigens
05/08/2007CA2102918C Genetic vaccine for immunodeficiency viruses
05/03/2007WO2007051201A2 Tlr3 glycosylation site muteins and methods of use
05/03/2007WO2007051063A2 Gpcr expressing cell lines and antibodies
05/03/2007WO2007051045A2 Compositions and methods for inhibiting expression of huntingtin gene
05/03/2007WO2007050798A2 Lrrtm1 compositions and methods of their use for the diagnosis and treatment of cancer
05/03/2007WO2007050734A1 Protein kinase a reporters useful in high throughput assays
05/03/2007WO2007050670A2 Expression construct maintenance
05/03/2007WO2007050651A1 Selective vpac2 receptor peptide agonists
05/03/2007WO2007050513A2 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity
05/03/2007WO2007050390A2 Botulinum neurotoxin a receptor and the use thereof
05/03/2007WO2007050121A2 Site specific pegylated hemoglobin, method of preparing same, and uses thereof
05/03/2007WO2007050057A1 Identification, expression, functions and uses of mda-bf factors
05/03/2007WO2007050043A2 Methods of specifying mesodermal, endodermal and mesoendodermal cell fates
05/03/2007WO2007049904A1 Peptides exhibiting efficacies of improvement in skin conditions or treatment of periodental diseases
05/03/2007WO2007049805A1 Synthetic lipopeptide and use thereof for medical purposes
05/03/2007WO2007049770A1 Outer coat protein pa5158 of pseudomonas aeruginosa
05/03/2007WO2007049695A1 Agglutinable glp-1 analogue and sustained-release pharmaceutical composition
05/03/2007WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same
05/03/2007WO2007049620A1 Diagnostic agent and therapeutic agent for disease associated with hepatocyte growth factor receptor
05/03/2007WO2007049117A1 A recombinant 12-kda protein useful for the detection of respiratory allergies
05/03/2007WO2007049065A2 Vwfa, collagen and kunitz domain containing protein
05/03/2007WO2007049062A2 Vwfa-domain containing proteins
05/03/2007WO2007049059A1 Gpr 26 g-protein coupled receptor
05/03/2007WO2007048830A2 Assays for histone deacetylase 1/2 selective inhibitors
05/03/2007WO2007048780A2 Nucleic acid molecules encoding phosphatidate cytidylyl-transferase-like polypeptides and methods of use
05/03/2007WO2007048638A2 Botulinum neurotoxin a protein receptor and uses thereof
05/03/2007WO2007048324A1 Bone morphogenetic protein-2-derived bioactive peptides and their preparing methods and uses
05/03/2007WO2007030937A3 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors
05/03/2007WO2007026171A3 Vdcc gamma-8 ion channel
05/03/2007WO2007025988A3 Liquid formulations of pegylated growth hormone
05/03/2007WO2007017590A3 Guar protein extract product and method for the production and use thereof
05/03/2007WO2007014244A3 Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
05/03/2007WO2007010399A3 Purified trimeric s protein as vaccine against severe acute respiratory syndrome virus infections
05/03/2007WO2007002574A3 Cspcna isoform modifications and uses thereof
05/03/2007WO2006136906B1 Switch-peptides as tool for the study of fibrillogenesis
05/03/2007WO2006132966A9 Webbed hiv envelope immunogens, methods for production and use of same
05/03/2007WO2006125714A3 Alleles of the opca gene from coryneform bacteria
05/03/2007WO2006125012A3 Compositions, methods and kits for real-time nucleic acid analysis in live cells
05/03/2007WO2006110762A3 Pharmaceutical compositions for and methods of inhibiting hcv replication
05/03/2007WO2006109192A8 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
05/03/2007WO2006099875A8 Antibodies against cd38 for treatment of multiple myeloma
05/03/2007WO2006038208A3 Agents capable of downregulating an msf-a - dependent hif-1α and use thereof in cancer treatment
05/03/2007WO2006023412A3 Biomarkers for osteoarthritis
05/03/2007WO2006017276A3 Recombinant rabies virus compositions
05/03/2007WO2005113596A3 Cell surface receptor isoforms and methods of identifying and using the same
05/03/2007WO2005103270A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying nitrogen use efficiency characteristics in plants
05/03/2007WO2005092069A8 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
05/03/2007WO2005026317A3 Polynucleotides encoding novel variants of the trp channel family member, ltrpc3
05/03/2007WO2004092350A3 G-protein coupled receptors
05/03/2007WO2004065575A3 Dna compositon and uses thereof
05/03/2007WO2004018643A3 Method for regulating dopamine producing cells
05/03/2007WO2003052049A3 Molecules for disease detection and treatment
05/03/2007WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
05/03/2007US20070101460 Nucleotide sequences and polypeptides encoded thereby useful for producing transformed plants expressing lethal/nonviability genes
05/03/2007US20070101459 Conditional sterility in plants
05/03/2007US20070101455 Castanea sativa mill. genes codifying for allene oxide cyclase, cystatin, beta-1, 3-glucanase and thaumatin-like protein and their use
05/03/2007US20070101454 Transgenic plants having increased soluble solids, lycopene, and improved plant volume or yield, increased anthocyanin in leaves, seedling vigor; improved resistance to cold, heat, freezing, low nitrogen and phosphorus conditions, osmotic stresses such as drought, and high salt
05/03/2007US20070101450 DNA that encodes a protein having high-affinity choline transporter activity
05/03/2007US20070101449 Transgenic animal having an amyloid precursor protein with a modified beta secretase cleavage site
05/03/2007US20070101448 Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use
05/03/2007US20070101446 Antibodies against epitopes with homology to self antigens, methods of preparation
05/03/2007US20070101444 Ion channel
05/03/2007US20070101443 Animal models; drug screening; uridine diphospho-glucuronosyl transferase; predicting likely behaviour of a drug in a selected species of primate
05/03/2007US20070100561 Crystals of DPP-IV
05/03/2007US20070100133 Erythropoietic compounds
05/03/2007US20070099861 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
05/03/2007US20070099860 Double-stranded ribonucleic acid (dsRNA), mediating RNA interference, Huntington's disease
05/03/2007US20070099838 Plant-derived peptides harboring water-cleaning and antimicrobial activities
05/03/2007US20070099837 Increasing cartilage deposition by administering a fibroblast growth factor homolog polypeptide to a fibrocartilage, hyaline, or elastic cartilage injury in patient; osteoarthritis treatment
05/03/2007US20070099834 Compositions and methods related to anti-FGF agents
05/03/2007US20070099833 Albumin fusion proteins
05/03/2007US20070099822 Regulation of tissue mineralization and phosphate metabolism by asarm peptides
05/03/2007US20070099820 Polymer-drug conjugates
05/03/2007US20070099296 Compositions and methods for determining susceptibility of hepatitis C virus to anti-viral drugs
05/03/2007US20070099275 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance
05/03/2007US20070099271 Transductin-1 and transductin-2 and applications to hereditary deafness
05/03/2007US20070099270 Novel neurotrophic factors
05/03/2007US20070099269 Cytokine zalpha11 ligand
05/03/2007US20070099268 Chimeric HCN channels
05/03/2007US20070099267 Combinatorial protein library screening by periplasmic expression
05/03/2007US20070099266 Process for the production of tumor necrosis factor-binding proteins
05/03/2007US20070099264 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis
05/03/2007US20070099263 Materials and methods relating to g-protein coupled receptor oligomers
05/03/2007US20070099262 Viral vectors expressing fusion of viral large envelope protein and protein of interest
05/03/2007US20070099248 Monovalent streptavidin compositions
05/03/2007US20070099247 Polypeptide Display Libraries and Methods of Making and Using Thereof
05/03/2007US20070099241 Method of detecting a subfraction of proBNP
05/03/2007US20070099232 Ecdysone receptor ligand-binding domain structure
05/03/2007US20070099231 Bioelastomer
05/03/2007US20070099230 Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecles, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor
05/03/2007US20070099226 determining whether a candidate compound is capable of modulating local intracellular cAMP concentration within a eukaryotic cell; whole-cell patch-clamp technique
05/03/2007US20070099217 Method for stress evaluation